Industry news
TransEnterix Inc. acquires robotic division of SOFAR. S.A. and TELELAP ALF-X for $99.8 million
TransEnterix, Inc. a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, announced that it has acquired the surgical robotics division of SOFAR S.p.A., an Italian health care company, in a cash and stock transaction with total consideration of $99.8 million. SOFAR has developed the TELELAP ALF-X advanced robotic system for minimally invasive surgery, which has an active CE Mark.